(E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide

C33H39N3O2 — CID 16992725

IUPAC(E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide
SMILESCc1ccc(C(C)C)c(OCCn2c(CCCCCNC(=O)/C=C/c3ccccc3)nc3ccccc32)c1
InChIInChI=1S/C33H39N3O2/c1-25(2)28-19-17-26(3)24-31(28)38-23-22-36-30-15-10-9-14-29(30)35-32(36)16-8-5-11-21-34-33(37)20-18-27-12-6-4-7-13-27/h4,6-7,9-10,12-15,17-20,24-25H,5,8,11,16,21-23H2,1-3H3,(H,34,37)/b20-18+
InChIKeyDKCFDDJKVZDUTQ-CZIZESTLSA-N
MW509.69 g/mol
LogP7.09
Rot. Bonds13

About (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide

(E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide (PubChem CID 16992725) has the molecular formula C33H39N3O2 and a molecular weight of 509.69 g/mol. Its IUPAC name is (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide.

Molecular Properties

Compound Name(E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide
PubChem CID16992725
Molecular FormulaC33H39N3O2
Molecular Weight509.69 g/mol
Exact Mass509.30
IUPAC Name(E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide
SMILESCc1ccc(C(C)C)c(OCCn2c(CCCCCNC(=O)/C=C/c3ccccc3)nc3ccccc32)c1
InChIInChI=1S/C33H39N3O2/c1-25(2)28-19-17-26(3)24-31(28)38-23-22-36-30-15-10-9-14-29(30)35-32(36)16-8-5-11-21-34-33(37)20-18-27-12-6-4-7-13-27/h4,6-7,9-10,12-15,17-20,24-25H,5,8,11,16,21-23H2,1-3H3,(H,34,37)/b20-18+
InChIKeyDKCFDDJKVZDUTQ-CZIZESTLSA-N
XLogP7.09
TPSA56.15 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds13
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500509.69
LogP ≤ 57.09
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide?
The IUPAC name of (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide (CID 16992725) is (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide.
What is the SMILES notation for (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide?
The canonical SMILES for (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide is Cc1ccc(C(C)C)c(OCCn2c(CCCCCNC(=O)/C=C/c3ccccc3)nc3ccccc32)c1.
What is the InChIKey of (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide?
The InChIKey is DKCFDDJKVZDUTQ-CZIZESTLSA-N. The full InChI is InChI=1S/C33H39N3O2/c1-25(2)28-19-17-26(3)24-31(28)38-23-22-36-30-15-10-9-14-29(30)35-32(36)16-8-5-11-21-34-33(37)20-18-27-12-6-4-7-13-27/h4,6-7,9-10,12-15,17-20,24-25H,5,8,11,16,21-23H2,1-3H3,(H,34,37)/b20-18+.
What are the key properties of (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide?
(E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide has a molecular weight of 509.69 g/mol, XLogP of 7.09, 13 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-N-[5-[1-[2-(5-methyl-2-propan-2-ylphenoxy)ethyl]benzimidazol-2-yl]pentyl]-3-phenylprop-2-enamide is sourced from PubChem (CID 16992725), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).